Real‐world data on the incidence, mortality, and cost of ischaemic stroke and major bleeding events among non‐valvular atrial fibrillation patients in England

RATIONALE, AIMS, AND OBJECTIVES: Several novel oral anticoagulants (NOACs) are licensed for atrial fibrillation (AF) treatment in the United Kingdom. We describe the incidence and mortality from ischaemic stroke and major bleeding in non‐valvular atrial fibrillation (NVAF) patients in England, inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakhai, Ameet, Petri, Hans, Vahidnia, Farnaz, Wolf, Cyrill, Ding, Yingjie, Foskett, Nadia, Sculpher, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891325/
https://www.ncbi.nlm.nih.gov/pubmed/32314853
http://dx.doi.org/10.1111/jep.13400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891325/
https://www.ncbi.nlm.nih.gov/pubmed/32314853
http://dx.doi.org/10.1111/jep.13400

Ejemplares similares